Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion type Assertion NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_head.
- NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion wasGeneratedBy ECO_0000203 NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_provenance.
- NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion wasDerivedFrom befree-20150227 NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_provenance.
- NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion SIO_000772 21715317 NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_provenance.
- NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion evidence source_evidence_literature NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_provenance.
- NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_assertion description "[Using the disease-specific expression of CD5, CD23, and CD160, a score of 3 characterized CLL (diagnostic odds ratio, 1430); a score of 0 excluded CLL, MCL, and HCL; and the CD23/CD5 ratio differentiated CLL from leukemic CD23(+) MCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396424.RA272Yo2D45xwTStFYB4MhzeeodovL5GEx-0CpvL0CV2k130_provenance.